Feasibility & Pilot Testing of Group-based ACT for Adolescents With

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Recurrent and impairing functional somatic syndromes (FSS) are common in adolescents. Despite a high need for care, empirically supported treatments are lacking for youth. The aim of the uncontrolled was to assess feasibility and treatment potential of group-based Acceptance and Commitment Therapy (ACT) in a generic treatment approach for adolescents with multiple FSS i.e. "ACT for Health in Adolescents" (AHEAD).

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04935307` - Central Processing of Odour Stimuli in Patients With Functional Somatic Disorder or MCS Compared to Healthy Controls	N/A
Completed	`NCT03694769` - Investigating Drop Attacks
Recruiting	`NCT06232473` - Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder	Phase 4

NCT number	NCT04464447
Study type	Interventional
Source	University of Aarhus
Contact
Status	Completed
Phase	N/A
Start date	May 29, 2013
Completion date	April 24, 2015

Feasibility and Pilot Testing of Group-based ACT for Adolescents With Functional Somatic Syndromes — AHEAD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms